SMTI Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
28.4M
+1.0%
28.1M
+1.2%
27.8M
+0.9%
27.5M
+4.6%
26.3M
Cost of Revenue
2.1M
+6.2%
2.0M
+3.0%
1.9M
+2.6%
1.9M
+0.0%
1.9M
Gross Profit
26.3M
+0.6%
26.2M
+1.1%
25.9M
+0.8%
25.7M
+5.0%
24.5M
Operating Expenses
25.6M
+5.0%
24.4M
+4.9%
23.2M
-5.7%
24.6M
+14.4%
21.5M
R&D
723.7K
-37.3%
1.2M
+52.0%
759.6K
-62.7%
2.0M
+97.7%
1.0M
SG&A
24.3M
+7.3%
22.6M
+3.3%
21.9M
+9.0%
20.1M
+1.0%
19.9M
Operating Income
736.0K
-58.7%
1.8M
-32.7%
2.6M
+151.9%
1.1M
-64.3%
2.9M
EBITDA
1.3M
-43.8%
2.4M
-25.8%
3.2M
-9.2%
3.6M
-10.6%
4.0M
Net Income
-1411193
-211.6%
-452864
-198.7%
458.6K
+128.5%
-1610158
+94.7%
-30412108
EPS (Basic)
$-0.16
-220.0%
$-0.05
-200.0%
$0.05
+126.3%
$-0.19
+94.6%
$-3.52
EPS (Diluted)
$-0.16
-220.0%
$-0.05
-200.0%
$0.05
+125.0%
$-0.20
+94.1%
$-3.40
Shares (Diluted)
8.8M
+1.4%
8.7M
-3.6%
9.0M
+11.6%
8.1M
-9.9%
8.9M
Sanara MedTech (SMTI) — Financials